Company Overview and News

 
Churchill Downs Incorporated Opens Derby City Gaming Bringing World’s Most Advanced Historical Racing Machines to Louisville

2018-09-14 globenewswire
LOUISVILLE, Ky., Sept. 14, 2018 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) is celebrating the grand opening of Derby City Gaming, a $65 million state-of-the-art historical racing machine (“HRM”) facility located at 4520 Poplar Level Road in Louisville, Kentucky. State and local officials and members of the horse racing community are joining the CDI team today to officially open the entertainment facility to the public.
AINSY CHDN AINSF AGI

 
Ainsworth Game Technology Ltd. ADR 2018 Q4 - Results - Earnings Call Slides

2018-08-30 seekingalpha
The following slide deck was published by Ainsworth Game Technology Ltd. ADR in conjunction with their 2018 Q4 earnings call.
AINSY AINSF AGI

 
Pokies add $8.32b in value to Australian economy, manufacturers say

2018-08-19 theage.com.au
Poker machine manufacturers have taken a provocative swipe at the industry’s critics, seizing on the findings of a soon-to-be-released study that estimates pokies contribute $8.32 billion in value added to the Australian economy every year.
AINSY ARLUF ALL AINSF AGI

 
Pokies add $8.32b in value to Australian economy, manufacturers say

2018-08-19 smh.com.au
Poker machine manufacturers have taken a provocative swipe at the industry’s critics, seizing on the findings of a soon-to-be-released study that estimates pokies contribute $8.32 billion in value added to the Australian economy every year.
AINSY ARLUF ALL AINSF AGI

 
Churchill Downs Incorporated Announces Increase from 600 to 900 Historical Racing Machines for the Opening of Derby City Gaming

2018-07-17 globenewswire
Kentucky Horse Racing Commission Also Conditionally Approves Ainsworth Game Technology Historical Racing Operating System and Initial Group of Game Themes for Derby City Gaming Machines
AINSY CHDN AINSF AGI

 
'A little bit of magic': The pokie that took over the world

2018-07-15 theage.com.au
Scott Olive has a saying about the poker machines he invents: “Our games are stronger for longer”.
AINSY AINSF AGI

 
'A little bit of magic': The pokie that took over the world

2018-07-15 smh.com.au
Scott Olive has a saying about the poker machines he invents: “Our games are stronger for longer”.
AINSY AINSF AGI

1
Len Ainsworth honoured for poker machines and philanthropy

2018-06-10 theage.com.au
Poker machine billionaire Len Ainsworth leads the list of corporate leaders in this year’s Queens Birthday Honours list.
AINSY ARLUF ALL AINSF AGI

1
Len Ainsworth honoured for poker machines and philanthropy

2018-06-10 smh.com.au
Poker machine billionaire Len Ainsworth leads the list of corporate leaders in this year’s Queens Birthday Honours list.
AINSY ARLUF ALL AINSF AGI

1
Len Ainsworth honoured for poker machines and philanthropy

2018-06-10 smh.com.au
Poker machine billionaire Len Ainsworth leads the list of corporate leaders in this year’s Queens Birthday Honours list.
AINSY ARLUF ALL AINSF AGI

 
Buffett not worried about China

2018-05-06 ntnews.com.au
The ASX 200 has climbed 1.85% over the week, recording its best weekly performance in 14 months. The index did decline on Friday though, slipping 0.6%.
ASXFF SRX SXMDF AINSY ASXFY SRXTY AINSF AGI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:AGI / AINSWORTH GAME TECHNOLOGY LIMITED on message board site Silicon Investor.

vitamins herbs supplements longevity and aging vitamins herbs supplements longevity and aging vitamins herbs supplements longevity and aging Agilent Technologies (A) Agilent Technologies (A) Agilent Technologies (A)
KapStone Paper and Packaging Corporation KapStone Paper and Packaging Corporation KapStone Paper and Packaging Corporation Magic Jack = CALL Magic Jack = CALL Magic Jack = CALL
EFII - Electronics for Imaging EFII - Electronics for Imaging EFII - Electronics for Imaging Magic Jack Magic Jack Magic Jack
Computerized Thermal Imaging CIO (formerly COII) Computerized Thermal Imaging CIO (formerly COII) Computerized Thermal Imaging CIO (formerly COII) Thermal imaging how it works in the Army and amongst gamers Thermal imaging how it works in the Army and amongst gamers Thermal imaging how it works in the Army and amongst gamers
TYPE MonoType Imaging TYPE MonoType Imaging TYPE MonoType Imaging MAGIC SOFTWARE-MGIC MAGIC SOFTWARE-MGIC MAGIC SOFTWARE-MGIC